Study objectives: Patients with COPD have an increased sympathetic modulation and reduced baroreflex sensitivity (BRS). Therefore, we studied the effects of breathing 31% supplemental oxygen (SuppO 2 ) on autonomic modulation in a group of COPD patients. Design: We measured autonomic modulation before and during the administration of SuppO 2 on 51 patients with COPD using time-frequency analysis of R-R intervals and BP before and after intervention. This was done via a counterbalanced crossover design. The BRS index was determined using the sequence method. Key words: autonomic modulation; baroreflex sensitivity; chronic obstructive lung disease; COPD; oxygen supplementation Abbreviations: BRS ϭ baroreceptor sensitivity; CA ϭ compressed air; HFln ϭ log-transformed high-frequency modulation; ln ϭ natural logarithm; SatO 2 ϭ oxygen saturation; SBP ϭ systolic BP; SuppO 2 ϭ 31% supplemental oxygen; TF ϭ time-frequency H ypoxia and hypercapnia have been shown to increase sympathetic nerve activity. Saito et al 1 demonstrated that the degree of hypoxia correlated with the degree of muscle nerve activity. Other studies have suggested that hypercapnia also leads to increases in muscle sympathetic traffic and that combined hypercapnia and hypoxia synergistically increase sympathetic activity 2,3 through impaired baroreceptor-cardiac reflex control. 4 Disruption of autonomic reflexes with increased sympathetic modulation, loss of vagal activity, and altered baroreceptor sensitivity (BRS) have been shown to be major risk factors for cardiac morbidity and mortality. [5] [6] [7] Since patients with COPD experience hypoxia and hypercapnia and since prior preliminary research has demonstrated reduced BRS in COPD patients, 8 we studied a group of patients with severe COPD to evaluate their autonomic modulation in response to breathing 31% supplemental oxygen (SuppO 2 ).
H ypoxia and hypercapnia have been shown to increase sympathetic nerve activity. Saito et al 1 demonstrated that the degree of hypoxia correlated with the degree of muscle nerve activity. Other studies have suggested that hypercapnia also leads to increases in muscle sympathetic traffic and that combined hypercapnia and hypoxia synergistically increase sympathetic activity 2,3 through impaired baroreceptor-cardiac reflex control. 4 Disruption of autonomic reflexes with increased sympathetic modulation, loss of vagal activity, and altered baroreceptor sensitivity (BRS) have been shown to be major risk factors for cardiac morbidity and mortality. [5] [6] [7] Since patients with COPD experience hypoxia and hypercapnia and since prior preliminary research has demonstrated reduced BRS in COPD patients, 8 we studied a group of patients with severe COPD to evaluate their autonomic modulation in response to breathing 31% supplemental oxygen (SuppO 2 ).
Materials and Methods

Subjects
Fifty-one patients with COPD were enrolled in the study. See Tables 1 for the subject characteristics and Table 2 for pulmonary profile data. All studies were carried out in the Human Performance Laboratory of the College of Physicians and Surgeons of Columbia University. All procedures were approved by the Human Subject Committee of Columbia University. Following the signing of the consent form, subjects were prepared for the data collection protocol. Subjects were recruited sequentially from the patients referred for exercise testing. All enrolled subjects had received established medical diagnoses of COPD with no other active respiratory disease. All subjects were instructed to maintain their normal daily routine and medications on the day of data collection but to refrain from taking any short-acting bronchodilators on the morning of data collection. Subjects were randomized to the order of the treatments.
Design
A counterbalanced crossover design after randomization was used.
Statistical Analysis
Paired t test comparisons were made between the two treatments for all dependent variables. Due to the number of t tests performed, we subjected all analyses to a Bonferroni correction, and p Ͻ 0.0125 was considered to be significant.
Data Acquisition
Preparatory Phase: Subjects were seated, at rest, and postabsorptive for at least 4 h and had refrained from consuming alcohol and caffeinated beverages for at least 12 h prior to the test. A multilead ECG was attached to the subject (model Max-1; Marquette Medical Systems; Milwaukee, WI). Respiration was recorded via amplified signals recorded from a thermistor (YSI reusable temperature probe; Yellow Springs, OH) placed under the subject's nostril. A radial artery pulse sensor for BP was attached to the subject's wrist to record beat-to-beat BP (model 7000; Colin Medical Instruments; San Antonio, TX). The BP was measured with the BP cuff at heart level on the right arm. Pulse oximetry was recorded using an index finger pulse oximeter (Sat-Trak Pulse Oximeter 767589 -103; SensorMedics; Yorba Linda, CA). The data were gathered while the subject was seated in an upright position. The environment in which they were seated was quiet with dimmed lighting, and subjects equilibrated to the environmental conditions for 15 min prior to the initiation of any data collection.
Data Collection: To remove bias, a Venturi mask was placed on the subject and either SuppO 2 or compressed air (CA) was delivered to the subject in a random order. There were two data-gathering protocols. Protocol 1 comprised the following: 15 min of equilibration while breathing O 2 ; 5 min of data collection while breathing O 2 ; followed by 15 min of equilibration while breathing CA; and 5 min of data collection while breathing CA. Protocol 2 comprised the following: 15 min of equilibration while breathing CA; 5 min of data collection while breathing CA; followed by 15 min of equilibration while breathing O 2 ; and 5 min of data collection while breathing O 2 . Randomization to a protocol was based on the patient's hospital identification number (odd number, protocol 1; even number, protocol 2). The total test duration was approximately 40 min (two trials with 15 min of equilibration on a new gas mixture in between). All data collection epochs were 5 min in duration, which is in accordance with the standards put forth by the Task Force on Standards of Heart Rate Variability Procedures. 9 Data gathering sessions included ECG recordings using lead II and lead V 5 , beat-by-beat BP recordings, oxygen saturation (SatO 2 ) levels, and respiration. During data collection, the subjects were instructed to breathe at a rate of 12 breaths/min for all collection periods. Breathing was regulated through the use of a pacing light that cycled 12 times a minute. All biopotentials were channeled through an interface board (BNC 2080; National Instruments; Austin TX) and were fed into a 12-bit analog-todigital converter (DAQCard-700; National Instruments) and then into a computer (Vision Book Plus; Hitachi; San Jose, CA) with a high-speed processor (Pentium; Intel; San Jose, CA). Postacquisition data analyses were carried out separately. All data were stored on the hard drive of the computer and were backed up daily using cartridges for exterior computer drives (Zip drive, Jaz drive; Iomega; Roy, UT).
Data Analysis
Time-Frequency Analysis: The current investigation used time and frequency or the Wigner-Ville distribution to decompose heart rate variability. This analysis is preferred over the traditional frequency spectral analysis due to the nonstationary nature of respiration in COPD patients. Specifically, the Wigner-Ville distribution decomposes a signal expressed as a function of time into a signal expressed as a function of both time and frequency. In this approach, the signal is divided into a series of short windows, and the Fourier transform then is calculated for each section. The problem with this approach is that as the time window is made shorter the frequency resolution decreases, resulting in a lessened ability to accurately determine the frequency content. In other words, there is a tradeoff between time resolution and frequency resolution. The time-frequency (TF) methods used herein do not suffer from the resolution problems described above and produce a distribution that is accurate in both time and frequency. The TF analysis employed herein, namely, the Wigner-Ville distribution, uses a modified Fourier transform applied to overlapping sections of the time signal to develop a joint density function that is dependent on both time and frequency. It has been shown to provide a reliable estimate of spectral powers without generating undesirable cross-terms. Furthermore, the Wigner-Ville distribution provides the most accurate estimate and the highest resolution. 10, 11 For a more detailed description on the Wigner-Ville distribution method of analysis, we refer the reader to Novak. 12 Due to the skewness of the data, a log transformation was performed.
BRS Assessment:
The spontaneous beat-by-beat interactions of systolic BP (SBP) and R-R interval reflect true baroreflex events rather than random interactions. 13 The R-R intervals were delineated via a peak detection algorithm described in previous work from our laboratory. 14 The spontaneous baroreflex response was determined from the beat-to-beat changes in the R-R interval and SBP by a modification of the technique of Bertinieri et al. 15 Linear regression was performed on any episode of three consecutive beats with R-R interval lags in the same direction (either up or down), and the resultant data yield an evaluation of the baroreflex sensitivity. 13 Verification of the correct breathing frequency of 12 breaths/min was made by visually counting the respiratory trace on the computer display panel as well as by spectrally decomposing the respiratory wave.
BP Variability Analysis
TF analysis was performed in a similar fashion to the heart rate variability analysis. In this technique, the systolic peaks are detected via a peak detection algorithm and then are interpolated and spectrally decomposed via the Wigner-Ville distribution.
Mean Heart Rate Analysis: Using the peak detection algorithm described in the article by Volterrani et al, 8 the mean interbeat intervals were calculated for the sample and were averaged to arrive at a mean heart rate.
Mean Pulse Pressure Analysis: Using the peak detection algorithm described in the article by De Meersman et al, 14 the mean SBP and diastolic BP were calculated as SBP-diastolic BP from an average of the entire sample. Figure 1 for HFln data and Figure 2 for BRS data. The low-frequency modulation/HFln ratio of heart rate variability revealed significant differences between the two treatments (SuppO 2 , 2.7 Ϯ 1.2; CA, 3.1 Ϯ 1.3; p Ͻ 0.008) (Fig 3) . The analysis of BP variability data revealed that there was a significant decrease in the logtransformed HFln (CA, 6.9 Ϯ 1.0 modulations/mm Hg 2 /Hz; SuppO 2 , 6.5 Ϯ 1.2 ln mm Hg 2 /Hz; p Ͻ 0.0001) (Fig 4) . The log-transformed low-frequency modulation of BP variability did not reveal any significant differences.
Results
Significant differences were seen in
Hemodynamic data revealed a decrease in mean heart rate while breathing SuppO 2 compared to that while breathing CA (CA, 87.3 Ϯ 13.3 beats/min; SuppO 2 , 85.0 Ϯ 12.4 beats/min; p Ͻ 0.0004) (Fig 5) . The arterial pulse pressure significantly decreased during breathing with SuppO 2 vs breathing with CA (CA, 57.2 Ϯ 13.5 mm Hg; SuppO 2 , 53.3 Ϯ 13.0 mm Hg; p Ͻ 0.0023) (Fig 6) . 
Discussion
The results of this investigation indicate that oxygen supplementation in COPD patients significantly and favorably alters autonomic modulation. Specifically, following breathing with SuppO 2 there is an augmentation in high-frequency cardiac modulation, an increased BRS, a decrease in heart rate, a decrease in high-frequency BP modulation, and a decrease in the mean pulse pressure. The increase in high-frequency cardiac modulation is representative of an increase in vagal tone. The lack of change in low-frequency modulation may be due to the presence of high sympathetic tone and the use of sympathetic agonists in many of these patients. The decrease in high-frequency modulation in BP is also consistent with improved vagal tone and with a possible modulation of the sympathetic tone. 16 Highfrequency BP modulation is known to be dependent on a combination of sympathetic and vagal tone, while low-frequency modulation is more purely sympathetic. Since there is little alteration of the lowfrequency component of BP variability, there is also probably little change in the sympathetic component of the high-frequency modulation. This leaves the vagal component of the high-frequency modulation as the most likely cause of the significant change seen in the high-frequency modulation. The decreases in pulse pressure and heart rate support these findings. This autonomic modulation may be due to a combination of factors, including reduced work of breathing, increased chemoreceptor sensitivity, and a reduction in pulmonary artery pressures.
Although the change in arterial pulse pressure was small, it is in the range of values found to correlate favorably with improved outcomes in a population of patients with cardiac disease. 17, 18 The heart rate is improved significantly, and larger heart rate changes have been shown to improve cardiac morbidity. 19 However, the significance of this small change is unclear, 20 other than as a marker of increased vagal tone. The BRS is in the range of high-risk patients in a population of patients with cardiac disease. These numbers are in the range of poor outcome expectations as seen in the recent Autonomic Tone and Reflexes After Myocardial Infarction trial. 21 The improvement in the BRS is approximately 17%, which is within the range that has been shown to improve outcomes in cardiac patients. 22 Although we are concerned with a different population in this study, the ability to induce a change with treatment may imply an improvement as well for individuals with COPD.
As hypercapnia and hypoxemia are strong stimulants to sympathetic activity, a higher basal autonomic tone could be expected between the subjects who were frankly hypoxemic (Pao 2 , Յ 60) and/or hypercapnic (Paco 2 , Ն 45) and those subjects who were less affected. The hypoxemic/hypercapnic group also may be expected to have different responses to the treatment with supplemental oxygen. Unfortunately, the number of subjects who fell into the severely affected group was too small to allow for a clear evaluation of these differences. The collection of more subjects in both the hypercapnic and hypoxemic groups should be undertaken to look at these issues.
Since the subject's respiratory rate, inspiratory time, and expiratory time were controlled for in this experiment, we would not expect significant changes in the work of breathing or in arterial CO 2 levels after SuppO 2 administration. For this reason, we would not expect this to cause stimulation of the chemoreceptors, which would affect autonomic modulation.
Pulmonary hypertension has been shown to be, at least in part, responsible for the attenuation of baroreflex responses in COPD patients. 4 It is for this reason that we speculate that the normalization of BRS in these individuals is partially due to a reduction in pulmonary arterial tension following breathing with SuppO 2 . The improved central venous SatO 2 level during SuppO 2 administration might decrease the level of pulmonary arterial vasoconstriction and right ventricular wall stress, in turn causing a decrease in sympathetic tone. This might happen via the nitric oxide-mediated pathway, which causes a direct relaxation of the pulmonary artery smooth muscle in the presence of increased oxygen tension.
Since chronic hypoxemia and its associated pulmonary hypertension have been shown to be major causes of morbidity and mortality, 23 these findings of improved autonomic modulation have particular clinical relevance. The long-term oxygen treatment trial and nocturnal oxygen treatment trial demonstrated the long-term benefits of SuppO 2 in the reduction of mortality in individuals with severe hypoxemia. Although the mechanisms of the reduction of mortality are not totally clear, these results established supplemental oxygen as the standard of care for these individuals. 24, 25 While these studies failed to demonstrate a reduction in pulmonary hypertension and cor pulmonale in patients with chronic hypoxemia, there appeared to be a reduction of the progression of pulmonary hypertension. This may have occurred via a reduction of hypoxic vasoconstriction and a reduction in basal vascular tone with the prevention of vascular smooth muscle hypertrophy. 26, 27 Our findings of increased vagal modulation may be an indication of a possible mechanism to describe the clinical finding mentioned above.
In conclusion, this study demonstrates that SuppO 2 in COPD patients significantly and favorably alters autonomic modulation. The exact mechanism by which this happens is not clear; however, future research involving measurements of pulmonary arterial pressures, nitric oxide levels, and endtidal CO 2 levels might hold the answer. These findings may be of special value in further supporting evidence of a cardioprotective role of SuppO 2 in patients with COPD.
